Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient

Jennifer L. Harcourt(Centers for Disease Control and Prevention), Natalie J. Thornburg(Oak Ridge Associated Universities)

bioRxiv (Cold Spring Harbor Laboratory)

March 3, 2020

10.1101/2020.03.02.972935

Cited by 155

Related Papers

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

|Emerging infectious diseases|2020|628

The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial

|The Lancet|2017|423